NEWARK, CA / ACCESSWIRE / September 5, 2023 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or "the Company") today announced that…
New app aims to revolutionize mental well-being through cutting-edge immersive experiences that make mindfulness meditation and breathwork more engaging &…
First Batch of 300,000 Units to be Fully Delivered in OctoberAinos Has Expanded Distribution in Multiple Channels and Plans to…
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information…
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on…
SYDNEY, AUSTRALIA, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage…
Folia Health Announces Expansion of HD, MS, MG cohorts By expanding their patient and caregiver user cohorts living with these…
SOLANA BEACH, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on…
GLP-1 Support from Solera can save tens of millions by streamlining step therapy and the prior authorization process for health…
CHARLESTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for…